This article is provided for educational and informational purposes only
Concurrently, advanced molecular therapeutics are emerging, including mitophagy inducers (e.g., urolithin A, nicotinamide riboside) to restore mitochondrial quality control (187, 188), gut microbiome engineering to reduce systemic inflammation (189), and innovative RNA therapeutics and gene circuits (e.g., olezarsen, the CHARM system) for long-term management of dyslipidemia (182, 183)
Exposure to bright or direct light can affect its stability, leading to a shorter shelf life
Chemical Degradation Kinetics of Recombinant Hirudin (HV1) in Aqueous Solution: Effect of pH
To date, any association with coronary heart disease was thought to be due to the saturated fat and cholesterol content of red meat
The treatment also decreased pro-inflammatory and pro-fibrotic gene expression with reduced macrophage infiltration (Li et al., 2025)